Order or notice
Kerala bans sale of six substandard ayurvedic and siddha batches (Jul 2026)
Last checked 10 October 2026
In Jul 2026 Kerala's Deputy Drugs Controller (Ayurveda) banned the sale and distribution in Kerala of six batches found substandard: Kasakalpa, Viswasasudharana, Swasakalpa, Swasa Spatikaamrutha, Vizzle (a siddha product) and Pain Niwaran Churna.
- Classification
- Prohibited under the Drugs and Cosmetics Act, 1940 (ASU and homoeopathic provisions)
- Decided by
- Deputy Drugs Controller (Ayurveda), Kerala
- Reference
- Kerala Drugs Control Department order, Jul 2026 (reported; the official site could not be read)
- Latest action
- 13 July 2026
- Last checked
- 10 October 2026
Photo: Ayurvedic herbs 02.jpg by Vis M (CC BY-SA 4.0). All photo credits.
Kerala bans sale and distribution of substandard ayurvedic medicines
Our team has checked this record against the published reports, last on 10 October 2026. The government order itself is not published online, or we have not found it yet, so we link the best public report. If you have the order, send it to us and we will link it instead.
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe explain what has been reported. The report above is the best source we hold.
Key facts
- Maruthi Pharma, Hyderabad
- Kasakalpa, Viswasasudharana, Swasakalpa
- Sri Venkateswara Ayur Pharma
- Swasa Spatikaamrutha
- Sanjeevi Pharma, Chennai
- Vizzle (a siddha product)
- Rajasthan Herbal International
- Pain Niwaran Churna
- Scope
- Sale and distribution banned in Kerala for the six batches
In Jul 2026 the Deputy Drugs Controller (Ayurveda) of Kerala banned the sale and distribution in Kerala of six batches of ayurvedic and siddha medicines found substandard, according to Kerala Kaumudi.
The products were Kasakalpa, Viswasasudharana and Swasakalpa from Maruthi Pharma of Hyderabad; Swasa Spatikaamrutha from Sri Venkateswara Ayur Pharma; Vizzle, a siddha product, from Sanjeevi Pharma of Chennai; and Pain Niwaran Churna from Rajasthan Herbal International.
The order applies to the named batches in Kerala only. The report does not give batch numbers or the test results, and the department's own site could not be read, so the product list follows the press report.
What this means for you
It is a batch order for one state
The ban covers six named batches and applies in Kerala. It does not ban these makers' other products or any other state's sales.
Check the batch
A batch number on the pack, not just the product name, decides whether a pack is covered. The report we read does not give batch numbers.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Why were the batches found substandard?
The report we read says only that the batches were found substandard. The reasons are not given.
Official sources and primary records
- News